A study from the Emory University School of Medicine finds transcranial magnetic stimulation (TMS), a targeted form of ...

In a first-of-its-kind clinical study, scientists at the University of Texas at Dallas and Baylor University Medical Center have shown that patients with treatment-resistant PTSD were symptom-free up ...

University of Queensland researchers are seeking participants diagnosed with PTSD and complex PTSD for a clinical study aimed at improving understanding of its impacts on the brain and overall ...

Credit: Getty Images. This study, centered on the US military population, sought to identify barriers to treatment for veterans and the effects of untreated PTSD. In patients with known trauma or ...

Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase ...

MAPS Public Benefit Corporation (MAPS PBC), the nonprofit’s clinical-stage private arm, published new data from its second multi-site, ethno-racially diverse Phase 3 clinical study of MDMA-assisted ...

In 2023, Australia became the first country in the world to allow health-care professionals to use a psychedelic drug to treat PTSD. This drug is MDMA, a synthetic compound commonly known as ecstasy.

After years of delays, researchers are set to move forward on a landmark clinical trial meant to evaluate the efficacy of smoked medical marijuana in treating post-traumatic stress disorder (PTSD) in ...

The leadership group for the Texas Biomedical Device Center includes, from left, Dr. Michael Kilgard, Dr. Jane Wigginton, Dr. Seth Hays and Dr. Robert Rennaker. In a first-of-its-kind clinical study, ...